Regulus Therapeutics
RGLS
#7200
Rank
NZ$1.03 B
Marketcap
NZ$14.92
Share price
0.00%
Change (1 day)
448.75%
Change (1 year)

Market capitalization of Regulus Therapeutics (RGLS)

Last known market cap: NZ$1.03 Billion

On August 27, 2025 Regulus Therapeutics had a market cap of NZ$1.03 Billion. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Regulus Therapeutics from 2012 to 2025

End of year Market Cap

Year Marketcap Change
2025NZ$0.97 B445.4%
2024NZ$0.17 B336.97%
2023NZ$40.93 M12.64%
2022NZ$36.33 M-46.02%
2021NZ$67.31 M-43.34%
2020NZ$0.11 B327.77%
2019NZ$27.77 M127.05%
2018NZ$12.23 M-91.96%
2017NZ$0.15 B-11.45%
2016NZ$0.17 B-74.38%
2015NZ$0.67 B-33.03%
2014NZ$1.00 B166.64%
2013NZ$0.37 B36.94%
2012NZ$0.27 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Sanofi
SNY
NZ$204.19 B 19,672.44%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
NZ$67.44 B 6,430.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$219.71 B 21,174.84%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$494.29 B 47,763.07%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
NZ$175.00 B 16,845.47%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sangamo Therapeutics
SGMO
NZ$56.04 M-94.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
NZ$5.44 B 427.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$35.21 B 3,309.66%๐Ÿ‡บ๐Ÿ‡ธ USA